The cardiovascular performance is pivotal for organ perfusion through the generation of pressure and flow, and the associated pathophysiology and therapies are key determinants of outcome in many patients admitted to the ICU. The complexities of ventriculo-arterial coupling and the variability of systemic to regional haemodynamic coherence are still incompletely understood and challenging to monitor, rendering their associated management arguably overly simplistic and targeting pattern recognition rather than the idiosyncrasies of single patients. The incidence of circulatory failure in patients admitted in the ICU is around 30% [1] . Atrial fibrillation may be observed in as high as 25% of critically ill patients [2] and is associated with increased length of ventilation and mortality [3] . In a large retrospective observational study in more than 14,000 unselected critically ill patients, in-ICU mortality was 9% in the overall population, while it was 78% in the subgroup of patients with severe hyperlactatemia [4] . The main causes of severe hyperlactatemia were septic (34%), cardiogenic (19%), and haemorrhagic (12%) shock and cardiopulmonary resuscitation (14%) [4] . In the SOAPII trial including 1679 patients, the main cause of circulatory failure was septic (62%), followed by cardiogenic (17%), hypovolaemic (16%), other types of distributive shock (4%) and obstructive (2%) shock [5] .
While the management of cardiac arrest has improved [6] , mortality associated with out-of-hospital cardiac arrest remains high. Novel, innovative and readily applicable scoring systems for early prediction of neurological outcome [7] are needed. They may serve to guide patient's selection for full code life support such as veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with refractory cardiogenic shock following resuscitation [8] . Recent advances in VA-ECMO technology helped improve outcomes in subgroups of patients with cardiogenic shock related to acute myocardial infarction [9] or fulminant myocarditis [10] . Whether such maximally invasive support in refractory cardiac arrest should be regionally coordinated within clinical networks deserves additional investigation.
Recent technological development allows better haemodynamic monitoring in patients using less invasive devices, more particularly, the use of echocardiography [11] . Modern ultrasound equipment is smaller, even down to pocket size, and provides better quality imaging. The role of miniaturized transoesophageal probes should be explored [12] . Future clinical trials need to address how monitoring of heart function and haemodynamics by echocardiography may impact on delivered therapies and ultimately patient-centred outcomes. The development of artificial intelligence and machine learning will allow monitors to become smart with the addition of decision support. This leads to interesting opportunities to improve the workflow within the ICU clinical team of doctors and nurses. While optimization of systemic haemodynamics has remained the cornerstone of clinical research and clinical trials over the last decades, especially focusing on fluid resuscitation [13] and blood pressure targets [14] , optimization of the microcirculation will likely get more attention in the future as new modalities of monitoring become applicable at the bedside. With the ageing population, an increasing number of elderly patients will become critically ill, meaning that the impact of ageing on cardiovascular physiology will need to be increasingly considered in a frail population [15] .
The evolution of electronic medical records, the potential to analyse big data and the development of new *Correspondence: antoine.vieillard-baron@aphp.fr 1 Intensive Care Unit, Section Thorax-Vascular Disease-Abdomen-Metabolism, Assistance Publique-Hôpitaux de Paris, University Hospital Ambroise Paré, 92100 Boulogne-Billancourt, France Full author information is available at the end of the article clinical trial designs using more extensive networks put cardiovascular studies in critically ill patients of a similar magnitude to cardiological cohorts within reach. Alongside such progress, clinical governance and audit are likely to improve with potential for more rapid and comprehensive guidelines to be embedded in practice. The understanding of heart function and central haemodynamics in the critically ill patient remains fundamentally insufficient unless the impact of the respiratory system and its management are also considered. In the most complex ICU patients, this comes close to 'a riddle, wrapped in a mystery, inside an enigma' .
An earlier call for papers on acute respiratory distress syndrome, sepsis and acute kidney injury proved immensely successful and resulted in the May 2016, December 2016 and June 2017 thematic issues of Intensive Care Medicine. A new call for papers focusing on cardiovascular issues in the ICU is now launched to be included in 2018. All manuscripts addressing any cardiovascular aspects of the critically ill patient will be considered. Intensive Care Medicine gives priority to high quality data, including large and multicentre welldesigned cohorts, prospective studies, randomized trials, and studies that use patient-reported outcomes. We hope that this call for papers will be successful and look forward to receiving manuscripts before the deadline of January 1st, 2018.
